An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib

Squamous cell carcinoma (SCC) transformation has been identified as a mechanism of resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), gefitinib or erlotinib, in EGFR-mutated lung cancer. However, whether second- or third-generation TKIs can overco...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Intern Med
Main Authors: Sato, Mitsuo, Matsui, Akira, Shimoyama, Yoshie, Omote, Norihito, Morise, Masahiro, Hase, Tetsunari, Tanaka, Ichidai, Suzuki, Kojiro, Hasegawa, Yoshinori
פורמט: Artigo
שפה:Inglês
יצא לאור: The Japanese Society of Internal Medicine 2018
נושאים:
Case Report
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6306534/
https://ncbi.nlm.nih.gov/pubmed/30101911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.0999-18
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים